Quantitative Interactomics in Primary T Cells Provides a Rationale for Concomitant PD-1 and BTLA Coinhibitor Blockade in Cancer ImmunotherapyJavier Celis‐Gutierrez, Bernard MALISSEN|Cell Reports|2019Cited by 154